LGMD2A clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
LGMD R1 Natural History Study
Sorry, in progress, not accepting new patients
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
Orange, California and other locations
Our lead scientists for LGMD2A research studies include Tahseen Mozaffar.
Last updated: